Lilly Reports One-Year Psoriatic Arthritis Results for Taltz-Zepbound Combination
Eli Lilly reported 52-week Phase 3b results for its Taltz and Zepbound combination, with sustained improvements in psoriatic arthritis.
Eli Lilly reported 52-week Phase 3b results for its Taltz and Zepbound combination, with sustained improvements in psoriatic arthritis.